Furthermore, PKC activation exacerbates endothelial dysfunction by inhibiting endothelial nitric oxide synthase (eNOS) and reducing nitric oxide (NO) bioavailability [28]. The gene discussed is NOS3; the disease is endothelial dysfunction.